User profiles for Robert Kossmann

Robert Kossmann

SVP & CMO, Fresenius Medical Care North America, Renal Therapies Group
Verified email at fmc-na.com
Cited by 536

Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study

RJ Kossmann, A Gonzales, R Callan… - Clinical Journal of the …, 2009 - journals.lww.com
Background and objectives: A bicarbonate dialysate acidified with citrate (CD) has been
reported to have local anticoagulant effect. This study examines the effect of CD on dialysis …

[HTML][HTML] Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis

CP Larsen, RJ Kossmann, ML Beggs, A Solomon… - Kidney international, 2014 - Elsevier
Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a recently described form of
amyloidosis that most frequently manifests clinically with progressive renal failure. In a series of …

[HTML][HTML] Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: a retrospective analysis of pharmacy data

…, C Mullon, FW Maddux, RJ Kossmann… - Clinical …, 2017 - ncbi.nlm.nih.gov
Aims: Hyperphosphatemia has been associated with an increased risk of mortality in
patients with end-stage renal disease. We sought to assess the real-world effectiveness of …

[HTML][HTML] Humoral response to mRNA versus an adenovirus vector-based SARS-CoV-2 vaccine in dialysis patients

…, C Mysayphonh, RJ Kossmann… - Clinical Journal of the …, 2021 - journals.lww.com
Patients on maintenance dialysis may be immunocompromised and have comorbidities that
modulate the response to coronavirus disease 2019 (COVID-19) vaccines. We conducted a …

[HTML][HTML] One-year historical cohort study of the phosphate binder sucroferric oxyhydroxide in patients on maintenance hemodialysis

…, NJ Ofsthun, S Davis, C Mullon, RJ Kossmann… - Journal of Renal …, 2019 - Elsevier
Objective The high pill burden of many phosphate binders (PBs) may contribute to increased
prevalence of hyperphosphatemia and poor nutritional status observed among patients …

Choosing home hemodialysis: a critical review of patient outcomes

…, R Himmele, DA Sawin, J Kim, RJ Kossmann - Blood purification, 2018 - karger.com
Background/Aim: Home hemodialysis (HHD) has been associated with improved clinical
outcomes vs. in-center HD (ICHD). The prevalence of HHD in the United States is still very low …

Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium—a review of its principles, applications, benefits, and risks

…, SJ Saggi, M Salifu, RJ Kossmann - Hemodialysis …, 2018 - Wiley Online Library
Dialysis dose is an important determinant of clinical outcomes in patients with end stage
renal disease on maintenance dialysis. In clinical practice dialysis dose is monitored at least …

Machine learning for prediction of patients on hemodialysis with an undetected SARS-CoV-2 infection

…, P Kotanko, JP Kooman, JL Hymes, RJ Kossmann… - Kidney360, 2021 - journals.lww.com
Background We developed a machine learning (ML) model that predicts the risk of a patient
on hemodialysis (HD) having an undetected SARS-CoV-2 infection that is identified after the …

Real-world scenario improvements in serum phosphorus levels and pill burden in peritoneal dialysis patients treated with sucroferric oxyhydroxide

…, C Kwoh, C Mullon, RJ Kossmann… - American journal of …, 2018 - karger.com
Background: A database analysis was conducted to assess the effectiveness of sucroferric
oxyhydroxide (SO) on lowering serum phosphorus and phosphate binder (PB) pill burden …

[HTML][HTML] Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical …

…, NV Athienites, C Mullon, RJ Kossmann… - BMC nephrology, 2019 - Springer
Background Elevated serum phosphorus concentrations are common among maintenance
hemodialysis patients. Protein is a major source of dietary phosphate, but restriction of …